Xylem Inc.

Valuation Analysis

About the Company

Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide. It operates through Water Infrastructure; Applied Water; Measurement and Control Solutions; and Water Solutions and Services segments. The company offers water, wastewater, and storm water pumps and controls and systems; filtration, disinfection, and biological treatment equipment under the Flygt, Ionpure, Leopold, Neptune Benson, Sanitare, Wallace & Tiernan, and Wedeco brands; and pumps, valves, heat exchangers, controls, and dispensing equipment used for water and focuses on the residential, commercial and industrial markets under the Rule, Bell & Gossett, Flojet, Go

Xylem Inc. Stock at a Glance

Xylem Inc. (XYL) is currently trading at $110.08 with a market capitalization of $26.2B. The trailing P/E ratio stands at 27.38x, with a forward P/E of 18.07x. The 52-week range spans from $105.29 to $154.27; the current price is 28.6% below the yearly high. Year-over-year revenue growth stands at +2.7%. The net profit margin stands at 10.79%.

💰 Dividend

Xylem Inc. pays an annual dividend of $1.72 per share, representing a yield of 1.56%. The payout ratio stands at 40.55%.

📊 Analyst Rating

17 analysts rate Xylem Inc. (XYL) on consensus: Buy. The average price target is $150.65, implying +36.85% from the current price. Analyst price targets range from $124.00 to $183.00.

Xylem Inc.: The Investment Case in Detail

Xylem Inc. (XYL) operates in the Industrials — specifically Specialty Industrial Machinery — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Wall Street consensus sits at Buy with an average price target implying roughly 36.85% upside from current levels — analyst sentiment is firmly constructive.

The Bear Case

Revenue growth has slowed to just 2.7%, which is below nominal GDP — the business is no longer outgrowing the broader economy.

What to Watch Next

• The forward P/E of 18.07x is meaningfully below the trailing 27.38x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 36.85% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Risk Profile

The data points to market-like volatility.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Xylem Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.